Protein disulfide isomerase as a novel target for cyclopentenone prostaglandins: implications for hypoxic ischemic injury

The FEBS Journal
Hao LiuRobert W Hickey

Abstract

Cyclooxygenase-2 (COX-2) is an important contributor to ischemic brain injury. Identification of the downstream mediators of COX-2 toxicity may allow the development of targeted therapies. Of particular interest is the cyclopentenone family of prostaglandin metabolites. Cyclopentenone prostaglandins (CyPGs) are highly reactive molecules that form covalent bonds with cellular thiols. Protein disulfide isomerase (PDI) is an important molecule for the restoration of denatured proteins following ischemia. Because PDI has several thiols, including thiols within the active thioredoxin-like domain, we hypothesized that PDI is a target of CyPGs and that CyPG binding of PDI is detrimental. CyPG-PDI binding was detected in vitro via immunoprecipitation and MS. CyPG-PDI binding decreased PDI enzymatic activity in recombinant PDI treated with CyPG, and PDI immunoprecipitated from neuronal culture treated with CyPG or anoxia. Toxic effects of binding were demonstrated in experiments showing that: (a) pharmacologic inhibition of PDI increased cell death in anoxic neurons, (b) PDI overexpression protected neurons exposed to anoxia and SH-SY5Y cells exposed to CyPG, and (c) PDI overexpression in SH-SY5Y cells attenuated ubiquitination of prote...Continue Reading

References

Jan 13, 2000·Chemistry & Biology·K J WoycechowskyR T Raines
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Mitsuhiro KondoKoji Uchida
Apr 24, 2003·The Journal of Biological Chemistry·Takahiro ShibataKoji Uchida
Sep 19, 2003·Antioxidants & Redox Signaling·Elizabeth A Kersteen, Ronald T Raines
Feb 28, 2004·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Ericka L FinkRobert S Clark
Jun 15, 2004·Biochemical and Biophysical Research Communications·Zongmin LiMaria E Figueiredo-Pereira
Sep 24, 2004·Journal of Neurochemistry·Donald J DeGracia, Heather L Montie
Jan 8, 2005·Stroke; a Journal of Cerebral Circulation·Costantino Iadecola, Philip B Gorelick
Aug 16, 2005·Chemical Research in Toxicology·David L CarboneDennis R Petersen
Jun 6, 2006·Pharmacology & Therapeutics·Sandra J HewettJames A Hewett
Dec 2, 2006·Trends in Neurosciences·Takumi Satoh, Stuart A Lipton
Apr 5, 2007·Nature Protocols·Andrej ShevchenkoMatthias Mann
Sep 26, 2007·The FEBS Journal·Feras Hatahet, Lloyd W Ruddock
Dec 7, 2007·Chemical Research in Toxicology·Koji Uchida, Takahiro Shibata
Dec 21, 2007·Biochimica Et Biophysica Acta·Christian Appenzeller-Herzog, Lars Ellgaard
Jun 10, 2008·Current Pharmaceutical Design·Eduardo Candelario-Jalil, Bernd L Fiebich
Oct 1, 2008·Current Opinion in Chemical Biology·Watson J Lees
May 12, 2009·Neuroscience Research·Elodie DescampsJoseph Vamecq
May 30, 2009·Antioxidants & Redox Signaling·Feras Hatahet, Lloyd W Ruddock
Jan 8, 2010·ACS Chemical Biology·Joris BeldDonald Hilvert
Mar 17, 2010·Proceedings of the National Academy of Sciences of the United States of America·Leonardus M I KoharudinAngela M Gronenborn
Jul 2, 2010·British Journal of Pharmacology·Katrin Andreasson
Aug 28, 2010·The FEBS Journal·Guennadi KozlovKalle Gehring
Nov 17, 2010·Nature Chemical Biology·Benjamin G HoffstromBrent R Stockwell
Dec 7, 2010·Biochemical and Biophysical Research Communications·Rituraj PalMahesh Narayan
Jan 27, 2011·Methods in Enzymology·Joachim D UysDanyelle M Townsend

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.